The probability of semaglutide being cost-effective reached 100% at a WTP threshold of approximately 9,000 per QALY gained
The only available study by Jensterle et al
When prescribed, clinicians typically consider: BMI requirements: Adults with obesity (typically BMI of 30 or higher), or overweight (BMI of 27 or higher) with at least one weight-related health condition like high blood pressure, type 2 diabetes, or high cholesterol Medical evaluation: A clinician reviews your complete health history before prescribing Certain medical conditions may make oral semaglutide inappropriate
Bottom line: Cigna Medicare Part D covers Wegovy only for the cardiovascular indication, not for weight loss alone FAQ Does Cigna Cover Wegovy for Weight Loss in 2026
MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome
Each of the three honorees played a role at a key moment: finding the new hormone